Results 231 to 240 of about 14,065,915 (293)

Hope on the horizon: Emerging therapies for hepatitis D. [PDF]

World J Hepatol
Abbas Z, Abbas M.
europepmc   +1 more source

Treatment response to bulevirtide is linked to amelioration of portal hypertension in patients with chronic hepatitis D. [PDF]

JHEP Rep
Sandmann L, Jachs M, Tergast TL, Hartl L, Bremer B, Kabelitz MA, Schwarz M, Egge JFM, Balcar L, Hofer BS, Falk CS, Stättermayer AF, Cornberg M, Trauner M, Deterding K, Mandorfer M, Wedemeyer H, Reiberger T, Maasoumy B.   +18 more
europepmc   +1 more source

A comprehensive review of diagnostic approaches for hepatitis D. [PDF]

Front Mol Biosci
Liu WH, Cui JY, Yu M, Shi XD, Che YL, Wang CY, Chi XM.   +6 more
europepmc   +1 more source

Proteins and peptides as antigen candidates for the immunodiagnosis of hepatitis D. [PDF]

Amino Acids
Xavier SR, Dos Santos Barcelos IC, Gandra IB, Pereira SP, Ribeiro AJ, Silva KA, Resende CAA, da Silva Lopes L, Machado RCR, Silva LMS, Silva LS, Ferreira LC, de Souza LFA, Souza RB, Passos-Silva AM, da Paz MC, Fumagalli MAC, Coelho EAF, Giunchetti RC, Machado JM, Gonçalves AAM, Dos Santos Pereira S, da Matta DA, Souza Vieira D, Galdino AS.   +24 more
europepmc   +1 more source

Updated hepatitis D seroprevalence among HBsAg-positive persons aged ≥6 years in the United States, National Health and Nutrition Examination Survey, 2007‒2018. [PDF]

Clin Infect Dis
Casillas SM, Chida A, Drobeniuc J, Sandul AL, Kamili S, Jiles RB, Thomas DL, Tobian AAR, Patel EU, Teshale EH.   +9 more
europepmc   +1 more source

Response-guided bulevirtide ± pegylated interferon alfa-2a: Long-term outcomes observed in the nationwide Austrian hepatitis D cohort study. [PDF]

JHEP Rep
Schwarz M, Hintersteininger M, Schwarz C, Panzer M, Pfisterer N, Loschko N, Hartl L, Dorn L, Laferl H, Trauner M, Stättermayer AF, Mandorfer M, Graziadei I, Maieron A, Moschen A, Aigner E, Stadlbauer V, Madl C, Aberle SW, Zoller H, Gschwantler M, Reiberger T, Jachs M.   +22 more
europepmc   +1 more source

The Challenge of Hepatitis D Virus Coinfection in Iran: Age, Access, and Unanswered Public Health Questions. [PDF]

Iran J Med Sci
Byeon H.
europepmc   +1 more source

The Medical Impact of Hepatitis D Virus Infection in Natives and Immigrants: The Italian Paradigm. [PDF]

Liver Int
Caviglia GP, Dileo E, Olivero A, Mengozzi G, Ciancio A, Loglio A, Viganò M, Fagiuoli S, Colombatto P, Coco B, Brunetto MR, Angrisani D, Galeota Lanza A, Magni C, Rizzardini G, Messina V, Milella M, Saracino A, Marinaro L, Cariti G, Cossiga V, Morisco F, Cretella S, Verucchi G, Biliotti E, D'Offizi G, Feasi M, Pontali E, Coppola C, Rapetti R, Pirisi M, Izzi A, Santantonio T, Di Marco V, Marrone A, Coppola N, Rizzi M, Cattelan AM, Niro GA, Toniutto P, Ponziani FR, Belli LS, Federico A, Bertino G, Barone M, Puoti M, Civolani A, Distefano M, Surace LA, Cozzolongo R, Cela EM, Teti E, Lampertico P, Stroffolini T, Rizzetto M, HDV Describe Study Group.   +55 more
europepmc   +1 more source

Applying the COM-B Model to Identify Barriers to Bulevirtide Adherence in Chronic Hepatitis D: A Multicenter Italian Study. [PDF]

J Viral Hepat
Badia L, Ciancio A, Distefano M, Izzi A, Loglio A.   +4 more
europepmc   +1 more source

Suboptimal Linkage to Care of Delta-Infected Patients in an Area with Increasing Migration-Driven Prevalence of Hepatitis D in Recent Years. [PDF]

Viruses
Carvalho-Gomes Â, Bono A, Gómez L, Sabater S, Rodríguez JC, Palau A, Forés A, Rodríguez M, Pascual S, Cebrià I Iranzo MÀ, Prieto M, Berenguer M.   +11 more
europepmc   +1 more source